{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "APOG",
  "name": "Apogee Enterprises, Inc.",
  "url": "https://frontierpicks.com/dossiers/APOG/",
  "json_url": "https://frontierpicks.com/dossiers/APOG.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Apogee Enterprises' pricing and cost gains drove a raise in fiscal 2027 adjusted EPS guidance to $3.00–$3.40 on 6 October 2026. The ~6 January 2027 quarterly report shows whether those margins hold with organic sales growth at only 4.6%.",
  "invalidation_trigger": "A daily close below $41, which would erase most of the 2026-10-06 post-earnings gain and fall under mid-October trading levels. A cut to the fiscal 2027 adjusted EPS guidance of $3.00–$3.40 at the next report would also end the case.",
  "catalyst_date": null,
  "pick": null,
  "themes": [
    "cyclical-industrials"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Apogee's fiscal year ends in late February or early March; the quarter ended 2026-08-29 is fiscal second-quarter 2027, so fiscal labels run a year ahead of the calendar year.",
    "Apogee reports both GAAP and adjusted EPS, and the gap can be material: fiscal Q2 2027 GAAP diluted EPS was $1.07 versus $1.17 adjusted.",
    "The Groglass acquisition was still pending as of the 2026-10-06 results release, so guidance may be revised when the deal closes."
  ],
  "body_markdown": "## Current Thesis\n\nApogee Enterprises has turned pricing discipline and cost work into higher margins, and on 2026-10-06 it raised fiscal 2027 adjusted earnings per share (EPS) guidance to $3.00–$3.40 from $2.70–$3.25. The case for the shares is that this earnings power holds. The fiscal third-quarter report, expected around 2027-01-06, settles it by showing whether margins stay up while organic growth runs at only mid-single digits.\n\nThe quarter ended 2026-08-29 was a clear beat. Adjusted EPS came in at $1.17 against a $0.63 consensus estimate (Benzinga), and net sales of $391.1 million topped the $359.5 million estimate. Sales grew 9.2%, but only 4.6% of that was organic. The acquired skylight maker Kalwall supplied the other 4.6 points, according to the company's 2026-10-06 8-K. So the profit story rests mainly on pricing and productivity, which management credited for the beat. Volume did little of the work.\n\nThe narrative is maturing. The beat-and-raise is three weeks old, and the only company news since 2026-10-06 is an officer's Form 4 filed 2026-10-29. Even so, the shares closed at $45.80 on 2026-10-29, 5.1% below their 52-week high of $48.27. The view that the guidance holds into the January report is wrong if the shares close below $41 or if that report trims the fiscal 2027 range.\n\n## Bull Case\n\n- **Margins rose on pricing and productivity.** Gross margin reached 24.6% in the quarter ended 2026-08-29, up 150 basis points, and operating margin rose 110 basis points to 8.6% (company 8-K, 2026-10-06).\n- **Guidance went up by more than the acquisition adds.** The company lifted the fiscal 2027 sales range to $1.46–$1.50 billion from $1.38–$1.43 billion on 2026-10-06. It also said Kalwall and the pending Groglass deal would have only a modest effect on fiscal 2027 adjusted EPS. Most of the $0.15–$0.30 EPS raise therefore comes from the existing businesses.\n- **Backlog keeps building.** Architectural Services backlog was $833.0 million at 2026-08-29, up from $792.3 million at the end of fiscal 2026 (8-K, 2026-10-06). That backlog supports revenue in the coming quarters.\n- **Cash still goes back to shareholders.** Year-to-date buybacks totaled $16.1 million and dividends $11.2 million through 2026-08-29. The company raised the quarterly dividend to $0.27 from $0.26.\n- **Earnings multiple looks moderate.** At the 2026-10-29 close of $45.80, the shares trade at about 14 times the $3.20 midpoint of the fiscal 2027 adjusted EPS guidance.\n\n## Bear Case\n\n- **Volume growth is thin.** Organic sales grew 4.6% in the quarter, and Architectural Glass organic sales fell 1.6% (8-K, 2026-10-06). Once price increases stop adding to sales, demand from commercial construction has to carry the growth.\n- **Material inflation squeezed some segment margins.** Performance Surfaces adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) margin slipped to 22.5% from 23.2%. Architectural Glass fell to 14.9% from 16.1% in the same quarter.\n- **Acquisitions added debt.** Long-term debt rose to $335.5 million at 2026-08-29 from $232.3 million at the end of fiscal 2026, after $99.6 million of acquisition spending. The credit-agreement leverage ratio stood at 1.7 times.\n- **GAAP earnings fell.** Diluted EPS under generally accepted accounting principles (GAAP) was $1.07, down from $1.10 a year earlier. Adjustments account for the whole improvement in the headline figure.\n- **An officer sold shares into the rally.** Matthew Christian, President of Architectural Services, sold 1,200 shares at $44.94 on 2026-10-27, according to an SEC Form 4. The filing does not mark the sale as part of a 10b5-1 trading plan. The sale is small next to his 36,381 remaining shares.\n\n## Setup & Price Structure\n\nThe shares closed at $45.80 on 2026-10-29, 5.1% below the 52-week high of $48.27, and are up 9.8% over three months, based on adjusted daily closes. The 14-day relative strength index (RSI) is 77.3, above the 70 level that usually marks short-term overbought conditions. That reading shows how fast the shares rose after the 2026-10-06 report, when they gained about 10% in a day (Benzinga).\n\nAn SEC Form 4 records a share-withholding price of $41.38 on 2026-10-16. That puts the $41 area roughly where the shares traded in mid-October, before the latest run. A daily close below $41 would erase most of the post-report gain. The $48.27 52-week high is the overhead reference.\n\nOn crowding, the overbought RSI and the officer's 2026-10-27 sale are the visible signs. No share issuance has been reported, and the next earnings date is more than 30 days away.\n\n## Catalyst Calendar (next 30 days)\n\n- **~2026-11-19, est. American Institute of Architects (AIA) Architecture Billings Index for October.** The index is a leading indicator of nonresidential construction demand, which is where Apogee sells its glass, framing and services.\n- **~2027-01-06, est. fiscal third-quarter 2027 report.** This falls outside the 30-day window but is the event the case turns on. It shows whether the $3.00–$3.40 guidance holds and whether margins stay above last year's levels.\n\n## Elapsed catalysts\n\n- **Undated — closing of the Groglass acquisition.** The company called the deal pending in its 2026-10-06 release. Closing would add revenue and debt, and the company expects a modest fiscal 2027 EPS effect. *(passed 24d ago)*\n\n## What Would Change Our Mind\n\nThe case breaks if the margin gains fade. Signs would be a fiscal 2027 adjusted EPS guidance cut at the January report, or an operating margin falling back toward the 7.5% of a year earlier. A second break would be Architectural Services backlog dropping below its $792.3 million fiscal 2026 year-end level, since that would show the pipeline shrinking.\n\nOn price, a daily close below $41 would give back most of the 2026-10-06 post-earnings move and invalidate the read that the market is pricing the guidance raise as durable. A further rise in material costs that spreads the Performance Surfaces margin squeeze to Architectural Metals would also weaken the case.\n\n## Correlation Notes\n\nApogee trades with commercial construction activity, aluminum and glass input costs, and interest rates, which set financing conditions for nonresidential building. Among cyclical-industrial peers, DMC Global (BOOM) shares the closest exposure through its Arcadia architectural building products unit. Ryerson (RYZ) and Cleveland-Cliffs (CLF) track metals pricing, which feeds into Apogee's costs. Herc (HRI) tracks construction equipment demand.\n\nThe Cyclical industrials group turned back to accelerating interest in the 2026-10-30 weekly read after a saturated reading on 2026-09-30. A rotation out of the group would weigh on the shares even if Apogee's own results hold. That risk is highest before the January report, which is the next company-specific evidence.",
  "first_seen": "2026-10-29",
  "last_analyzed": "2026-10-30T07:52:47+00:00",
  "last_synthesized": "2026-10-30",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}